ADMA Biologics, Inc. Investors: Company Investigated by the Portnoy Law Firm

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Oct. 10, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises ADMA Biologics, Inc. (“ADMA Biologics” or “the Company”) (NASDAQ: ADMA) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors. ADMA Biologics investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq. Investors are encouraged to ...